GGS
ABBV icon

Galvin Gaustad & Stein’s AbbVie ABBV Stock Holding History

Galvin Gaustad & Stein’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.82M Buy
6,941
+46
+0.7% +$11.8K 0.14% 100
2026
Q2 		$1.74M Buy
6,895
+1,031
+18% +$222K 0.13% 103
2026
Q1 		$1.28M Buy
5,864
+297
+5% +$65.9K 0.1% 115
2025
Q4 		$1.27M Buy
5,567
+61
+1% +$13.9K 0.1% 108
2025
Q3 		$1.27M Buy
5,506
+629
+13% +$128K 0.1% 94
2025
Q2 		$905K Sell
4,877
-1
-0% -$186 0.08% 105
2025
Q1 		$1.02M Buy
4,878
+673
+16% +$131K 0.09% 97
2024
Q4 		$747K Sell
4,205
-28
-0.7% -$5.15K 0.07% 110
2024
Q3 		$836K Buy
4,233
+763
+22% +$142K 0.07% 103
2024
Q2 		$595K Buy
3,470
+16
+0.5% +$2.65K 0.06% 118
2024
Q1 		$629K Sell
3,454
-69
-2% -$11.9K 0.06% 108
2023
Q4 		$546K Sell
3,523
-419
-11% -$61.1K 0.05% 115
2023
Q3 		$588K Sell
3,942
-96,897
-96% -$14.2M 0.06% 107
2023
Q2 		$13.6M Sell
100,839
-9,619
-9% -$1.41M 1.32% 34
2023
Q1 		$17.6M Sell
110,458
-1,842
-2% -$282K 1.73% 24
2022
Q4 		$18.1M Buy
112,300
+6,352
+6% +$974K 1.83% 21
2022
Q3 		$14.2M Sell
105,948
-5,796
-5% -$832K 1.51% 29
2022
Q2 		$17.1M Sell
111,744
-17,273
-13% -$2.64M 1.74% 23
2022
Q1 		$20.9M Sell
129,017
-24,162
-16% -$3.51M 1.89% 16
2021
Q4 		$20.7M Sell
153,179
-10,115
-6% -$1.19M 1.79% 18
2021
Q3 		$17.6M Buy
+163,294
New +$18.7M 1.7% 19

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Galvin Gaustad & Stein's ABBV Position: Q3 2026 in Review

Galvin Gaustad & Stein increased its AbbVie (ABBV) stake by 0.67% in Q3 2026, buying an estimated $11.8K and bringing the position to 6,941 shares worth $1.82M. The position accounts for 0.14% of the portfolio, ranked #100.

Galvin Gaustad & Stein first reported a position in ABBV in Q3 2021 and has held it in 21 quarters since. The position peaked at $20.9M in Q1 2022. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Galvin Gaustad & Stein held 6,941 shares of AbbVie worth $1.82M as of Q3 2026.
  • Galvin Gaustad & Stein bought 46 AbbVie shares in Q3 2026, an estimated $11.8K.
  • AbbVie made up 0.14% of Galvin Gaustad & Stein's portfolio in Q3 2026, its #100 holding.
  • Galvin Gaustad & Stein first reported a position in AbbVie in Q3 2021 and has held it in 21 quarters since.
  • Galvin Gaustad & Stein's AbbVie position peaked at $20.9M in Q1 2022.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q3 2026, filed 8 Oct 2026.